Chinese Traditional and Herbal Drugs
|
2025, 56(13): 4621-4633
Preparation, characteration and in vivo evaluation of steviosin-cryptotanshinone self-micellizing solid dispersions based on “combined drug-excipient” strategy
Full
SHANG Dan1, ZHANG Guanghui1, LI Xiaoting1, LI Juan1, LI Guo1, FANG Wei2
Affiliations
1 Zhengzhou University of Industrial Technology, Zhengzhou 451150, China; 2 The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450001, China
About Author:
河南省高等学校重点科研项目 (24B310010); 河南省医学教育研究项目 (WJLX2024191); 教育部产学研合作协同育人项目 (230802175007047)
doi: 10.7501/j.issn.0253-2670.2025.13.007
Outline
Objective To prepare steviosin-cryptotanshinone self-micelle solid dispersion (Ste/Cry-SMSD), and investigate oral bioavailability and hypoglycemic effects. Methods Encapsulation efficiency and drug loading of self-assembled micelles acted as evaluation indexes, the formulation of Ste/Cry-SMSD was optimized by Box-Behnken design-response surface method. Crystal form of cryptotanshinone in Ste/Cry-SMSD powder was analyzed by X-ray powder diffraction (XRPD), combining mechanism was studied by Fourier transform infrared spectroscopy (FT-IR), morphology of self-assembled micelles was observed by transmission electron microscopy (TEM) and drug release behaviors in simulated gastrointestinal fluid were also investigated by dialysis bag method. The relative oral bioavailability of Ste/Cry-SMSD was investigated in comparison with cryptotanshinone. Diabetic model was established, and the glucose-decreasing effects and oral glucose tolerance of Ste/Cry-SMSD were compared with those of cryptanshinone. Results Optimal formulation of Ste/Cry-SMSD: the steviosin concentration is 2.70 mg/mL, preparation temperature is 52.0 ℃, and stirring time is 60.00 min. Encapsulation efficiency, drug loading, particle size and ζ potential of self-assembled micelles were (94.77 ±0.57)%, (8.11 ±0.06)%, (8.69 ±0.56) nm and (−16.19 ±0.92) mV, respectively. Cryptotanshinone and steviosin might be hydrogen-bonded and existed in the amorphous form in Ste/Cry-SMS powders. Drug release behaviors of Ste/Cry-SMSD in simulated gastrointestinal fluid were conformed to Weibull model. Pharmacokinetic results showed that Cmax of Ste/Cry-SMSD was increased to (1 129.34 ±206.13) ng/mL, t1/2 was prolonged to (4.15 ±0.82) h. The relative bioavailability of Ste/Cry-SMSD was increased to 6.11-fold compared to cryptotanshinone. Ste/Cry-SMSD significantly enhanced glucose-decreasing effects, blood glucose regulation ability and oral glucose tolerance of cryptotanshinone. Conclusion Ste/Cry-SMSD prescription was simple, which significantly increased the relative oral bioavailability and enhanced the glucose-decreasing effects of cryptotanshinone.
cryptotanshinone
/
steviosin
/
self-assembled micelles
/
combined drug-excipient
/
Box-Behnken design-response surface method
/
drug release behavior
/
pharmacokinetic
/
bioavailability
/
hypoglycemic effects
尚丹, 张广辉, 李晓婷, 李娟, 李果, 房伟.
基于“药辅合一”的甜菊素-隐丹参酮自胶束化固体分散体制备、表征及体内评价.
中草药,
2025
, 56
(13)
: 4621
-4633
.
DOI: 10.7501/j.issn.0253-2670.2025.13.007
SHANG Dan, ZHANG Guanghui, LI Xiaoting, LI Juan, LI Guo, FANG Wei.
Preparation, characteration and in vivo evaluation of steviosin-cryptotanshinone self-micellizing solid dispersions based on “combined drug-excipient” strategy[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(13)
: 4621
-4633
.
DOI: 10.7501/j.issn.0253-2670.2025.13.007
Year 2025 volume 56 Issue 13
45
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.13.007
- Receive Date:2025-01-22
- Online Date:2026-11-12